Efficacy and Safety of Yokukansan in Autism Spectrum disorder: A Randomized, Multi-center, Double-Blind, Placebo-Controlled Trial
Not Applicable
- Conditions
- Autism Spectrum Disorder
- Registration Number
- JPRN-UMIN000015708
- Lead Sponsor
- Shimane University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Presence of any active medical condition, diagnosis of any other psychiatric disorder on the DSM-5, use of any psychotropic medication in the six weeks prior to the baseline visit and history of hepatic disease or seizure could exclude the subject from this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Aberrant behavior checklist
- Secondary Outcome Measures
Name Time Method